TRIBALTO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 7.516
EU - Europa 652
AS - Asia 343
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 8.516
Nazione #
US - Stati Uniti d'America 7.513
DE - Germania 260
SG - Singapore 140
CN - Cina 127
UA - Ucraina 117
IE - Irlanda 66
RU - Federazione Russa 54
GB - Regno Unito 44
HK - Hong Kong 32
FI - Finlandia 26
IT - Italia 24
FR - Francia 23
KR - Corea 22
SE - Svezia 20
BE - Belgio 9
JP - Giappone 8
TH - Thailandia 6
CA - Canada 3
CZ - Repubblica Ceca 3
PL - Polonia 3
EU - Europa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BR - Brasile 1
IL - Israele 1
IN - India 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
NL - Olanda 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
UZ - Uzbekistan 1
Totale 8.516
Città #
Woodbridge 2.466
Wilmington 1.882
Houston 1.844
Chandler 244
Ann Arbor 164
Singapore 132
Fairfield 128
Jacksonville 107
Seattle 68
Dublin 66
Dearborn 63
Ashburn 53
Medford 47
New York 44
Cambridge 40
Beijing 34
Hong Kong 32
Santa Clara 25
Zhengzhou 24
Lawrence 22
Hefei 14
Mülheim 14
Rome 13
Moscow 11
Saint Petersburg 10
Mountain View 9
Brussels 8
Menlo Park 8
Nanchang 8
Nanjing 8
Munich 7
University Park 7
Detroit 6
Shanghai 6
Chiang Mai 5
Kunming 5
Louisville 5
Redwood City 5
San Diego 5
Helsinki 4
Milan 4
Nancy 4
Wuhan 4
Berlin 3
Boardman 3
Brno 3
Chicago 3
Falls Church 3
Fuzhou 3
Hebei 3
Jinan 3
Norwalk 3
Nürnberg 3
Verona 3
Banks 2
Guangzhou 2
Hounslow 2
Kraków 2
London 2
Montréal 2
Palo Alto 2
Tokyo 2
Almaty 1
Amman 1
Bangkok 1
Chengdu 1
Chongqing 1
Clifton 1
Easton 1
Hangzhou 1
Indiana 1
Leawood 1
Lima 1
Los Angeles 1
Manila 1
Markham 1
Oldenburg 1
Oxford 1
Phnom Penh 1
Phoenix 1
Pune 1
Raleigh 1
Redmond 1
San Francisco 1
São Paulo 1
Tel Aviv 1
Tianjin 1
Tirana 1
Uppsala 1
Zhoushan 1
Ürümqi 1
Totale 7.733
Nome #
Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-α (IFN-α) therapy 479
Treatment of multiple myeloma: A randomized study of three different regimens 446
Recombinant interferon alfa-2b (INTRON A) as post-induction therapy for responding multiple myeloma patients. M84 protocol 445
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 438
Non-Hodgkin lymphomas of the central nervous system 430
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 430
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia 427
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 424
Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas 409
FISH analysis for CML monitoring? 392
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 391
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 386
Biological and clinical advances in multiple myeloma: A review 379
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 377
Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (M0) 371
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatment 362
Early responder myeloma: Kinetic studies identify a patient subgroup characterized by very poor prognosis 350
Smouldering multiple myeloma 339
Bone marrow processing with a gravity sedimentation technique: experience of 13 cases 339
Increased level of circulating interleukin-6 in patients with newly diagnosed non-Hodgkin's lymphoma 339
Simultaneous occurrance of monoclonal gammopathy and acute secondary leukemia with overexpression of p-glycoprotein 291
[Current aspects of treatment of multiple myeloma] 287
Totale 8.531
Categoria #
all - tutte 14.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.001 0 0 0 0 0 0 216 178 162 174 117 154
2020/20211.101 133 144 104 152 104 124 137 106 31 9 47 10
2021/2022230 3 31 2 17 2 23 8 9 13 19 9 94
2022/2023424 43 47 47 61 33 84 27 23 28 1 27 3
2023/2024112 10 3 4 3 8 47 2 6 0 1 1 27
2024/2025293 22 124 60 29 19 11 28 0 0 0 0 0
Totale 8.531